ABSTRACT
phenylvaleric, phenyl-lactic, phenylpropionic, phenylmandelic and phenylhydracrylic acid [28] .
88
In the last years, several studies focused on the bioactivity of polyphenols and polyphenol-rich that polyphenols effects may be mediated also by the regulation of PON1 activity and gene 96 expression. In the present review, we attempt to summarize the main evidence on the potential 97 effects of polyphenols and polyphenol-rich foods on PON1 expression and activity also 98 considering, when available, the contribution of genetic factors and the mechanisms of action.
99
The review will focus on both in vitro and in vivo studies.
100

2.OVERVIEW OF IN VITRO AND IN VIVO STUDIES ON POLYPHENOLS AS 101
MODULATORS OF PON1 EXPRESSION AND ACTIVITY 102
A systematic search for literature focused on the effect of polyphenols and polyphenol-rich and/or in humans; 2-be a study evaluating PON-1 activity and/or expression; 3-be a study 113 evaluating polyphenols and/or polyphenol-rich foods. Exclusion criteria: a) evaluating foods not 114 having polyphenols as major bioactive compounds; b) performed in vitro but not using cells; c) found the optimal induction of intracellular and extracellular PON1 activity within 2-20 μM of 141 resveratrol while no effect was observed at doses higher than 20 μM, which in turn resulted 142 cytotoxic leading to a decrease of cell metabolic activity.
143
Three studies found a dose-dependent in increase of PON1 activity [42, 45, 46] documented that a 12-week intervention with extra virgin olive oil (25 mL/day) did not affect 291 serum PON1 activity in young and elderly healthy subjects.
292
A comparison of findings from animal and human studies testing the same food products 293 appears difficult since most of the animal studies used larger doses compared to those in human 294 trials. To give an example, the supplementation with 5-10 mL/day of pomegranate juice in mice 295 weighting 200 g would correspond to 1.75-3.5 L/day when consumed by a subject of 70 kg.
296
Thus, an appropriate extrapolation of animal dose to human dose and viceversa through 297 normalization to the body surface area should be used.
299
HYPOTHESIZED MECHANISMS OF PON1 REGULATION TROUGH POLYPHENOLS 300
In Recently, Atrahymovic and colleagues showed that the isoflavan glabridin could link re-PON1, 368 despite the high hydrophobic subunit, protecting re-PON1 in a dose-dependent (1−100 μM) 369 manner [125] . The authors hypothesized that the mechanism governing the protective effect was 370 not related to the antioxidant action, but rather to a physical interaction with the enzyme. The 371 bind glabridin-re-PON1 affected the enzyme structure and significantly enhanced the ability of 372 the enzyme to remove Ox-LDL associated cholesteryl ester hydroperoxides.
373
The different chemical structure of polyphenols and the impact of PON1 polymorphisms in the 374 response make it difficult to elucidate the ability of these dietary compounds to modulate PON1 375 activity and gene expression and the specific mechanisms involved. 
